{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:23:33Z","timestamp":1780392213641,"version":"3.54.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Astellas Pharma Singapore Pte. Ltd."}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Overactive bladder is underdiagnosed and undertreated in men as symptoms overlap with benign prostatic obstruction. This study identified barriers urologists encountered in effectively managing overactive bladder in men with lower urinary tract symptoms. 60 urologists recruited across Australia, Brazil, Colombia, Russia, South Korea and Thailand via convenience sampling participated in in-depth interviews. They were asked about their understanding and management of overactive bladder in men with lower urinary tract symptoms. Thematic analysis identified six themes: (1) overactive bladder diagnosis in men with lower urinary tract symptoms is complicated by the multi-factorial causes of storage symptoms; (2) patient-reported outcome tools are underutilized by urologists; (3) stigmatization and normalization of overactive bladder discourage men from seeking care; (4) challenges exist in tracking overactive bladder symptoms and in patient-urologist communication; (5) the underestimation of overactive bladder contributes to the non-urgency of its management; and (6) urologists may not fully appreciate the trade-offs between different overactive bladder treatments. Encouraging patient-reported outcome tool usage and differentiating the safety profiles of antimuscarinics and beta-3 agonists may facilitate timelier overactive bladder diagnosis and increase confidence in adding-on treatment.<\/jats:p>","DOI":"10.1371\/journal.pone.0328723","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:25:45Z","timestamp":1753291545000},"page":"e0328723","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Barriers to early and effective overactive bladder management in male patients with lower urinary tract symptoms"],"prefix":"10.1371","volume":"20","author":[{"given":"Paul","family":"Rasner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7358-4000","authenticated-orcid":true,"given":"Maria","family":"Arcila-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ailton Fernandes","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umaphorn","family":"Nuanthaisong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3373-3668","authenticated-orcid":true,"given":"Eric","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"pone.0328723.ref001","author":"International Continence Society"},{"issue":"3","key":"pone.0328723.ref002","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000447205","article-title":"Overactive Bladder Syndrome: Evaluation and Management","volume":"11","author":"E Leron","year":"2018","journal-title":"Curr Urol"},{"key":"pone.0328723.ref003","author":"International Continence Society"},{"key":"pone.0328723.ref004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2147\/TCRM.S269318","article-title":"Assessing Quality-of-Life of Patients Taking Mirabegron for Overactive Bladder","volume":"19","author":"C Shaw","year":"2023","journal-title":"Ther Clin Risk Manag"},{"issue":"6","key":"pone.0328723.ref005","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study","volume":"50","author":"DE Irwin","year":"2006","journal-title":"Eur Urol Goes Platin"},{"issue":"4","key":"pone.0328723.ref006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/tre.867","article-title":"Busting for change: a care pathway for overactive bladder","volume":"13","author":"J Kovacic","year":"2022","journal-title":"Trends Urol & Men\u2019s Health"},{"issue":"4","key":"pone.0328723.ref007","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1756287209350383","article-title":"Overactive bladder in males","volume":"1","author":"A Gomelsky","year":"2009","journal-title":"Ther Adv Urol"},{"issue":"1","key":"pone.0328723.ref008","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/luts.12193","article-title":"Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study","volume":"11","author":"Y-C Chuang","year":"2019","journal-title":"Low Urin Tract Symptoms"},{"issue":"8","key":"pone.0328723.ref009","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/03007995.2020.1760806","article-title":"Impact of OAB symptoms on work, quality of life and treatment-seeking behavior in Brazil","volume":"36","author":"CM Gomes","year":"2020","journal-title":"Curr Med Res Opin"},{"key":"pone.0328723.ref010","author":"International Continence Society","year":"2018"},{"issue":"2","key":"pone.0328723.ref011","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.maturitas.2011.11.016","article-title":"Overactive bladder: diagnosis and management","volume":"71","author":"D Robinson","year":"2012","journal-title":"Maturitas"},{"issue":"4","key":"pone.0328723.ref012","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.euf.2019.10.019","article-title":"Mirabegron add-on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: a randomized, placebo-controlled study (MATCH)","volume":"6","author":"H Kakizaki","year":"2020","journal-title":"Eur Urol Focus"},{"key":"pone.0328723.ref013","author":"JN Cornu","year":"2025"},{"issue":"1","key":"pone.0328723.ref014","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JU.0000000000003985","article-title":"The AUA\/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder","volume":"212","author":"AP Cameron","year":"2024","journal-title":"J Urol"},{"issue":"3","key":"pone.0328723.ref015","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.eururo.2018.03.020","article-title":"Efficacy and Tolerability of Mirabegron Compared with Antimuscarinic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis","volume":"74","author":"C Kelleher","year":"2018","journal-title":"Eur Urol"},{"key":"pone.0328723.ref016","author":"R West","year":"2020"},{"key":"pone.0328723.ref017","doi-asserted-by":"crossref","first-page":"114523","DOI":"10.1016\/j.socscimed.2021.114523","article-title":"Sample sizes for saturation in qualitative research: A systematic review of empirical tests","volume":"292","author":"M Hennink","year":"2022","journal-title":"Soc Sci Med"},{"issue":"8","key":"pone.0328723.ref018","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082859","article-title":"Lower urinary tract symptoms and overactive bladder in a large cohort of older Poles\u2014A representative tele-survey","volume":"12","author":"M Przydacz","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"pone.0328723.ref019","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12894-019-0513-1","article-title":"Epidemic investigation of benign prostatic obstruction with coexisting overactive bladder in Shanghai Pudong New Area and its impact on the health-related quality of life","volume":"19","author":"Q-T Yi","year":"2019","journal-title":"BMC Urol"},{"issue":"4","key":"pone.0328723.ref020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.eururo.2010.06.007","article-title":"Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic review","volume":"58","author":"DE Irwin","year":"2010","journal-title":"Eur Urol"},{"issue":"3","key":"pone.0328723.ref021","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA\/SUFU Guideline Amendment 2019","volume":"202","author":"DJ Lightner","year":"2019","journal-title":"J Urol"},{"key":"pone.0328723.ref022","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2013.02.2380","article-title":"Validation of an electronic bladder diary application","volume":"189","author":"JG Blaivas","year":"2013","journal-title":"J Urol"},{"key":"pone.0328723.ref023","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2296-15-96","article-title":"The patient perspective on overactive bladder: a mixed-methods needs assessment","volume":"15","author":"FA Filipetto","year":"2014","journal-title":"BMC Fam Pract"},{"issue":"11","key":"pone.0328723.ref024","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/ijcp.12882","article-title":"Nocturia is often inadequately assessed, diagnosed and treated by physicians: results of an observational, real-life practice database containing 8659 European and US-American patients","volume":"70","author":"M Oelke","year":"2016","journal-title":"Int J Clin Pract"},{"issue":"3","key":"pone.0328723.ref025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5213\/inj.1632534.267","article-title":"Diagnostic Tool for Assessing Overactive Bladder Symptoms: Could the International Prostate Symptom Storage Subscore Replace the Overactive Bladder Symptom Score?","volume":"20","author":"JS Shim","year":"2016","journal-title":"Int Neurourol J"},{"issue":"4","key":"pone.0328723.ref026","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.juro.2009.12.029","article-title":"Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry","volume":"183","author":"ST Mahajan","year":"2010","journal-title":"J Urol"},{"issue":"18","key":"pone.0328723.ref027","doi-asserted-by":"crossref","DOI":"10.12968\/bjon.2022.31.18.S16","article-title":"Overactive bladder: not just a normal part of getting older","volume":"31","author":"L Carpenter","year":"2022","journal-title":"Br J Nurs"},{"issue":"11","key":"pone.0328723.ref028","article-title":"Physician-patient communication about overactive bladder: Results of an observational sociolinguistic study","volume":"12","author":"SR Hahn","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"pone.0328723.ref029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13033-022-00546-7","article-title":"Mechanisms of action for stigma reduction among primary care providers following social contact with service users and aspirational figures in Nepal: an explanatory qualitative design","volume":"16","author":"BN Kaiser","year":"2022","journal-title":"Int J Ment Health Syst"},{"issue":"7","key":"pone.0328723.ref030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052105","article-title":"What are the barriers to the diagnosis and management of chronic respiratory disease in sub-Saharan Africa? A qualitative study with healthcare workers, national and regional policy stakeholders in five countries","volume":"12","author":"S Mulupi","year":"2022","journal-title":"BMJ Open"},{"issue":"2","key":"pone.0328723.ref031","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5455\/msm.2016.28.129-132","article-title":"medication adherence in elderly with polypharmacy living at home: a systematic review of existing studies","volume":"28","author":"E Zelko","year":"2016","journal-title":"Mater Socio-Medica"},{"issue":"1","key":"pone.0328723.ref032","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eururo.2019.09.024","article-title":"Safety and efficacy of mirabegron: analysis of a large integrated clinical trial database of patients with overactive bladder receiving mirabegron, antimuscarinics, or placebo","volume":"77","author":"CR Chapple","year":"2020","journal-title":"Eur Urol"},{"issue":"4","key":"pone.0328723.ref033","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1742-1241.2010.02611.x","article-title":"Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review","volume":"65","author":"SA Kaplan","year":"2011","journal-title":"Int J Clin Pract"},{"key":"pone.0328723.ref034","doi-asserted-by":"crossref","first-page":"101707","DOI":"10.1016\/j.cont.2024.101707","article-title":"A historical perspective on anticholinergics in overactive bladder (OAB) treatment: \u201cFoundations, current practices, and future prospects\u201d","volume":"12","author":"DC Ochoa","year":"2024","journal-title":"Continence"},{"issue":"4","key":"pone.0328723.ref035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/JU.0000000000003209","article-title":"Effect of pharmacotherapy for overactive bladder on the incidence of and factors related to urinary tract infection: a systematic review and meta-analysis","volume":"209","author":"K Tsubouchi","year":"2023","journal-title":"J Urol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0335425","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328723","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T17:25:50Z","timestamp":1753291550000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0328723"}},"subtitle":[],"editor":[{"given":"Stanis\u0142aw Jacek","family":"Wro\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0328723","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}